2 assets in Hutchinson-Gilford Progeria Syndrome

Therapeutic assets addressing Hutchinson-Gilford Progeria Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Progerinin Hutchinson-Gilford Progeria Syndrome	PRG Science & Technology Co., Ltd.	P2	B (60)
Lonafarnib Hutchinson-Gilford Progeria Syndrome	PRG Science & Technology Co., Ltd.	P2	B (58)